Relapse of Lymphoma after Allogeneic Hematopoietic Cell Transplantation: Management Strategies and Outcome-Reference-Cited by-同舟云学术

Relapse of Lymphoma after Allogeneic Hematopoietic Cell Transplantation: Management Strategies and Outcome

Published:2011-10 Issue:10 Volume:17 Page:1497-1504
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Wudhikarn Kitsada,Brunstein Claudio G.,Bachanova Veronika,Burns Linda J.,Cao Qing,Weisdorf Daniel J.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference40 articles.

1. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin’s disease and non-Hodgkin’s lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells;Nademanee;J Clin Oncol,1994

2. Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin’s lymphoma: an Italian multicenter randomized trial;Martelli;J Clin Oncol,2003

3. High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma (NHL) in adults;Greb;Cochrane Database Syst Rev,2008

4. Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin’s lymphoma;Rezvani;J Clin Oncol,2008

5. Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-Hodgkin lymphomas;Hamadani;Biol Blood Marrow Transplant,2009

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differentiating Between Epstein-Barr Virus–positive Lymphoid Neoplasm Relapse and Post-transplant Lymphoproliferative Disorder After Sex-mismatched Hematopoietic Stem Cell Transplantation;American Journal of Surgical Pathology;2024-01-30

2. Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012;Transplantation and Cellular Therapy;2022-07

3. Targeting the immune microenvironment in mantle cell lymphoma: implications for current and emerging therapies;Leukemia & Lymphoma;2022-06-15

4. A CASE OF DIFFUSE LARGE B-CELL LYMPHOMA TRANSFORMED FROM FOLLICULAR LYMPHOMA WITH SUCCESSFUL GRAFT-VERSUS-LYMPHOMA EFFECT ON EARLY RELAPSE AFTER CORD BLOOD TRANSPLANTATION;Japanese Journal of Transfusion and Cell Therapy;2021-12-24

5. Graft Versus Leukemia: Current Status and Future Perspectives;Journal of Clinical Oncology;2021-02-10